Handelsbanken Fonder’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $343M | Sell |
1,362,464
-19,132
| -1% | -$4.12M | 0.98% | 14 |
|
|
2026
Q1 | $300M | Buy |
1,381,596
+62,707
| +5% | +$13.9M | 1% | 14 |
|
|
2025
Q4 | $301M | Buy |
1,318,889
+52,526
| +4% | +$12M | 0.91% | 15 |
|
|
2025
Q3 | $293M | Sell |
1,266,363
-23,442
| -2% | -$4.77M | 0.93% | 15 |
|
|
2025
Q2 | $239M | Buy |
1,289,805
+92,262
| +8% | +$17.1M | 0.85% | 14 |
|
|
2025
Q1 | $251M | Buy |
1,197,543
+6,336
| +0.5% | +$1.23M | 1.03% | 15 |
|
|
2024
Q4 | $212M | Buy |
1,191,207
+45,266
| +4% | +$8.32M | 0.81% | 16 |
|
|
2024
Q3 | $226M | Buy |
1,145,941
+16,817
| +1% | +$3.14M | 0.9% | 15 |
|
|
2024
Q2 | $194M | Sell |
1,129,124
-50,261
| -4% | -$8.33M | 0.84% | 17 |
|
|
2024
Q1 | $215M | Buy |
1,179,385
+5,633
| +0.5% | +$971K | 0.92% | 16 |
|
|
2023
Q4 | $182M | Sell |
1,173,752
-51,912
| -4% | -$7.57M | 0.88% | 19 |
|
|
2023
Q3 | $183M | Sell |
1,225,664
-102,124
| -8% | -$15M | 1.02% | 12 |
|
|
2023
Q2 | $179M | Sell |
1,327,788
-43,965
| -3% | -$6.45M | 0.96% | 14 |
|
|
2023
Q1 | $219M | Sell |
1,371,753
-27,200
| -2% | -$4.16M | 1.26% | 12 |
|
|
2022
Q4 | $226M | Sell |
1,398,953
-12,223
| -0.9% | -$1.87M | 1.42% | 8 |
|
|
2022
Q3 | $189M | Buy |
1,411,176
+31,027
| +2% | +$4.45M | 1.27% | 10 |
|
|
2022
Q2 | $211M | Buy |
1,380,149
+110,261
| +9% | +$16.8M | 1.37% | 10 |
|
|
2022
Q1 | $206M | Sell |
1,269,888
-107,985
| -8% | -$15.7M | 1.15% | 12 |
|
|
2021
Q4 | $187M | Sell |
1,377,873
-3,495
| -0.3% | -$413K | 0.92% | 18 |
|
|
2021
Q3 | $149M | Buy |
1,381,368
+12,219
| +0.9% | +$1.4M | 0.78% | 22 |
|
|
2021
Q2 | $154M | Sell |
1,369,149
-30,287
| -2% | -$3.41M | 0.8% | 21 |
|
|
2021
Q1 | $151M | Buy |
1,399,436
+30,365
| +2% | +$3.25M | 0.86% | 22 |
|
|
2020
Q4 | $147M | Buy |
1,369,071
+73,410
| +6% | +$7.05M | 0.89% | 17 |
|
|
2020
Q3 | $113M | Buy |
1,295,661
+75,120
| +6% | +$7.07M | 0.83% | 18 |
|
|
2020
Q2 | $120M | Buy |
1,220,541
+446,641
| +58% | +$39.3M | 1% | 16 |
|
|
2020
Q1 | $59M | Buy |
773,900
+131,695
| +21% | +$11.2M | 1.27% | 18 |
|
|
2019
Q4 | $56.9M | Buy |
642,205
+2,200
| +0.3% | +$183K | 0.98% | 30 |
|
|
2019
Q3 | $48.5M | Buy |
640,005
+158,505
| +33% | +$10.9M | 0.98% | 27 |
|
|
2019
Q2 | $35M | Buy |
481,500
+380,000
| +374% | +$29.9M | 0.65% | 47 |
|
|
2019
Q1 | $8.18M | Sell |
101,500
-460,826
| -82% | -$37.7M | 0.16% | 140 |
|
|
2018
Q4 | $51.8M | Buy |
562,326
+36,985
| +7% | +$3.25M | 1.05% | 30 |
|
|
2018
Q3 | $49.7M | Sell |
525,341
-69,500
| -12% | -$6.59M | 0.93% | 36 |
|
|
2018
Q2 | $55.1M | Sell |
594,841
-120,000
| -17% | -$11.7M | 1.08% | 29 |
|
|
2018
Q1 | $67.7M | Buy |
714,841
+7,000
| +1% | +$769K | 1.33% | 17 |
|
|
2017
Q4 | $68.5M | Sell |
707,841
-41,000
| -5% | -$3.86M | 1.5% | 17 |
|
|
2017
Q3 | $66.5M | Hold |
748,841
| – | – | 1.54% | 18 |
|
|
2017
Q2 | $54.3M | Buy |
748,841
+71,000
| +10% | +$4.77M | 1.39% | 22 |
|
|
2017
Q1 | $44.2M | Sell |
677,841
-22,000
| -3% | -$1.38M | 1.23% | 27 |
|
|
2016
Q4 | $43.8M | Buy |
699,841
+30,000
| +4% | +$1.83M | 1.34% | 20 |
|
|
2016
Q3 | $42.2M | Sell |
669,841
-17,271
| -3% | -$1.12M | 1.24% | 23 |
|
|
2016
Q2 | $42.5M | Sell |
687,112
-23,500
| -3% | -$1.43M | 1.74% | 11 |
|
|
2016
Q1 | $40.6M | Sell |
710,612
-188,213
| -21% | -$10.5M | 1.73% | 13 |
|
|
2015
Q4 | $53.2M | Buy |
+898,825
| New | +$51.8M | 1.03% | 16 |
|
Other funds holding ABBV
ECSS
ATO
Handelsbanken Fonder's ABBV Position: Q2 2026 in Review
Handelsbanken Fonder reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $4.12M and leaving 1,362,464 shares worth $343M. The position accounts for 0.98% of the portfolio, ranked #14.
Handelsbanken Fonder first reported a position in ABBV in Q4 2015 and has held it in 43 quarters since. 1,965 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Handelsbanken Fonder held 1,362,464 shares of AbbVie worth $343M as of Q2 2026.
- Handelsbanken Fonder sold 19,132 AbbVie shares in Q2 2026, an estimated $4.12M.
- AbbVie made up 0.98% of Handelsbanken Fonder's portfolio in Q2 2026, its #14 holding.
- Handelsbanken Fonder first reported a position in AbbVie in Q4 2015 and has held it in 43 quarters since.
- 1,965 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.